| Year |
Citation |
Score |
| 2024 |
Shahid A, MacLennan S, Jones BR, Sudderuddin H, Dang Z, Cobarrubias K, Duncan MC, Kinloch NN, Dapp MJ, Archin NM, Fischl MA, Ofotokun I, Adimora A, Gange S, Aouizerat B, ... ... Goldstein H, et al. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time. Journal of Virology. e0165523. PMID 38214547 DOI: 10.1128/jvi.01655-23 |
0.537 |
|
| 2023 |
Shahid A, MacLennan S, Jones BR, Sudderuddin H, Dang Z, Cobarrubias K, Duncan MC, Kinloch NN, Dapp MJ, Archin NM, Fischl MA, Ofotokun I, Adimora A, Gange S, Aouizerat B, ... ... Goldstein H, et al. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time. Research Square. PMID 37645749 DOI: 10.21203/rs.3.rs-3259040/v1 |
0.557 |
|
| 2022 |
Anthony-Gonda K, Ray A, Su H, Wang Y, Xiong Y, Lee D, Block A, Chilunda V, Weiselberg J, Zemelko L, Wang YY, Kleinsorge-Block S, Reese JS, de Lima M, Ochsenbauer C, ... ... Goldstein H, et al. In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells. Jci Insight. 7. PMID 36345941 DOI: 10.1172/jci.insight.161698 |
0.653 |
|
| 2022 |
Pathela P, Qasmieh S, Gandhi M, Rozen E, Okochi H, Goldstein H, Herold BC, Jamison K, Schillinger JA, Nash D. Use of remnant specimens to assess use of HIV pre-exposure prophylaxis (PrEP) among populations with risk for HIV infection: A novel approach. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 35357337 DOI: 10.1097/QAI.0000000000002992 |
0.564 |
|
| 2021 |
Li M, Garforth SJ, O'Connor KE, Su H, Lee DM, Celikgil A, Chaparro RJ, Seidel RD, Jones RB, Arav-Boger R, Almo SC, Goldstein H. T-cell receptor-specific immunotherapeutics drive selective in vivo HIV and CMV-specific T-cell expansion in humanized mice. The Journal of Clinical Investigation. PMID 34673568 DOI: 10.1172/JCI141051 |
0.784 |
|
| 2021 |
Kinloch NN, Ren Y, Alberto WDC, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D, Harris M, Kovacs C, Benko E, Ostrowski MA, Del Rio Estrada PM, ... ... Goldstein H, et al. Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature Communications. 12: 2958. PMID 33986282 DOI: 10.1038/s41467-021-23515-z |
0.471 |
|
| 2021 |
Kinloch NN, Ren Y, Conce Alberto WD, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D, Harris M, Kovacs C, Benko E, Ostrowski MA, Del Rio Estrada PM, ... ... Goldstein H, et al. HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature Communications. 12: 165. PMID 33420062 DOI: 10.1038/s41467-020-20442-3 |
0.585 |
|
| 2020 |
Powell AB, Ren Y, Korom M, Saunders D, Hanley PJ, Goldstein H, Nixon DF, Bollard CM, Lynch RM, Jones RB, Cruz CRY. Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV. Molecular Therapy. Methods & Clinical Development. 19: 78-88. PMID 33005704 DOI: 10.1016/J.Omtm.2020.08.015 |
0.682 |
|
| 2020 |
Powell A, Ren Y, Korom M, Saunders D, Hanley P, Goldstein H, Nixon D, Bollard C, Lynch R, Jones R, Cruz C. Engineered antigen-specific T cells secreting broadly neutralizing antibodies: combining innate and adaptive immune response against HIV Cytotherapy. 22: S123-S124. DOI: 10.1016/J.Jcyt.2020.03.232 |
0.664 |
|
| 2019 |
Anthony-Gonda K, Bardhi A, Ray A, Flerin N, Li M, Chen W, Ochsenbauer C, Kappes JC, Krueger W, Worden A, Schneider D, Zhu Z, Orentas R, Dimitrov DS, Goldstein H, et al. Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model. Science Translational Medicine. 11. PMID 31391322 DOI: 10.1126/Scitranslmed.Aav5685 |
0.799 |
|
| 2019 |
Wu Y, Xue J, Wang C, Li W, Wang L, Chen W, Prabakaran P, Kong D, Jin Y, Hu D, Wang Y, Lei C, Yu D, Tu C, Bardhi A, ... ... Goldstein H, et al. Rapid elimination of broadly neutralizing antibodies correlates with treatment failure in the acute phase of SHIV infection. Journal of Virology. PMID 31375583 DOI: 10.1128/Jvi.01077-19 |
0.509 |
|
| 2019 |
Flerin NC, Bardhi A, Zheng JH, Korom M, Folkvord J, Kovacs C, Benko E, Truong R, Mota T, Connick E, Jones RB, Lynch RM, Goldstein H. Establishment of A Novel Humanized Mouse Model To Investigate Activation and Depletion of Patient-Derived HIV Latent Reservoirs. Journal of Virology. PMID 30626677 DOI: 10.1128/Jvi.02051-18 |
0.691 |
|
| 2019 |
Anthony-Gonda K, Bardhi A, Ray A, Krueger W, Schneider D, Zhu Z, Orentas R, Dimitrov D, Goldstein H, Dropulic B. Multispecific anti-HIV duoCAR-T cell therapy mediates robust HIV suppression and elimination of HIV-infected cells in humanised mice Journal of Virus Eradication. 5: 47. DOI: 10.1016/S2055-6640(20)30196-5 |
0.713 |
|
| 2018 |
Ren Y, Korom M, Truong R, Chan D, Huang SH, Kovacs CC, Benko E, Safrit JT, Lee J, Garbán H, Apps R, Goldstein H, Lynch RM, Jones RB. Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs. Journal of Virology. PMID 30209173 DOI: 10.1128/Jvi.00895-18 |
0.581 |
|
| 2017 |
Bardhi A, Wu Y, Chen W, Zhu Z, Zheng JH, Wong H, Jeng E, Jones J, Ochsenbauer C, Kappes JC, Dimitrov DS, Ying T, Goldstein H. Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein. Journal of Virology. PMID 28794022 DOI: 10.1128/Jvi.00937-17 |
0.718 |
|
| 2017 |
Flerin NC, Chen H, Glover TD, Lamothe PA, Zheng JH, Fang JW, Ndhlovu ZM, Newell EW, Davis MM, Walker BD, Goldstein H. TCR Clonotype-specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T Cell Clones is Not Mediated by TCR Alone. Journal of Virology. PMID 28077649 DOI: 10.1128/Jvi.02412-16 |
0.641 |
|
| 2017 |
Flerin N, Bardhi A, Zheng JH, Korom M, Lynch R, Jones RB, Goldstein H. Evaluation of the in vivo capacity of broadly neutralising anti-HIV antibodies to eliminate latently infected cells from HIV-infected individuals using a novel humanised mouse model Journal of Virus Eradication. 3: 16-17. DOI: 10.1016/S2055-6640(20)30596-3 |
0.685 |
|
| 2016 |
Chen W, Bardhi A, Feng Y, Wang Y, Qi Q, Li W, Zhu Z, Dyba MA, Ying T, Jiang S, Goldstein H, Dimitrov DS. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1. Mabs. 0. PMID 26963639 DOI: 10.1080/19420862.2016.1160180 |
0.457 |
|
| 2016 |
Thomas T, Seay K, Zheng JH, Zhang C, Ochsenbauer C, Kappes JC, Goldstein H. High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis. Methods in Molecular Biology (Clifton, N.J.). 1354: 221-35. PMID 26714715 DOI: 10.1007/978-1-4939-3046-3_15 |
0.72 |
|
| 2015 |
Seay K, Khajoueinejad N, Zheng JH, Kiser P, Ochsenbauer C, Kappes JC, Herold B, Goldstein H. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. Journal of Virology. 89: 9559-70. PMID 26157126 DOI: 10.1128/Jvi.01326-15 |
0.712 |
|
| 2015 |
Seay K, Church C, Zheng JH, Deneroff K, Ochsenbauer C, Kappes JC, Liu B, Jeng EK, Wong HC, Goldstein H. In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice. Journal of Virology. 89: 6264-74. PMID 25833053 DOI: 10.1128/Jvi.00563-15 |
0.66 |
|
| 2015 |
Costantini LM, Irvin SC, Kennedy SC, Guo F, Goldstein H, Herold BC, Snapp EL. Engineering and exploitation of a fluorescent HIV-1 gp120 for live cell CD4 binding assays. Virology. 476: 240-8. PMID 25555152 DOI: 10.1016/J.Virol.2014.12.019 |
0.553 |
|
| 2015 |
Babad J, Mukherjee G, Follenzi A, Ali R, Roep BO, Shultz LD, Santamaria P, Yang OO, Goldstein H, Greiner DL, DiLorenzo TP. Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice. Clinical and Experimental Immunology. 179: 398-413. PMID 25302633 DOI: 10.1111/Cei.12465 |
0.381 |
|
| 2014 |
Nixon B, Fakioglu E, Stefanidou M, Wang Y, Dutta M, Goldstein H, Herold BC. Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease. The Journal of Infectious Diseases. 209: 510-22. PMID 23990571 DOI: 10.1093/Infdis/Jit472 |
0.673 |
|
| 2013 |
Seay K, Qi X, Zheng JH, Zhang C, Chen K, Dutta M, Deneroff K, Ochsenbauer C, Kappes JC, Littman DR, Goldstein H. Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy. Plos One. 8: e63537. PMID 23691059 DOI: 10.1371/Journal.Pone.0063537 |
0.686 |
|
| 2012 |
Kipp DR, Hirschi JS, Wakata A, Goldstein H, Schramm VL. Transition states of native and drug-resistant HIV-1 protease are the same. Proceedings of the National Academy of Sciences of the United States of America. 109: 6543-8. PMID 22493227 DOI: 10.1073/Pnas.1202808109 |
0.388 |
|
| 2012 |
Seay K, Qi X, Zheng J, Dutta M, Ochsenbauer C, Kappes J, Santambrogio L, Littman D, Goldstein H. GM-CSF treatment enables mice transgenic for CD4-specific expression of human CD4, CCR5 and CyclinT1 to support in vitro and in vivo HIV infection Journal of Reproductive Immunology. 94: 128-129. DOI: 10.1016/J.Jri.2012.03.484 |
0.551 |
|
| 2010 |
Suh HS, Cosenza-Nashat M, Choi N, Zhao ML, Li JF, Pollard JW, Jirtle RL, Goldstein H, Lee SC. Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders. The American Journal of Pathology. 177: 2446-58. PMID 20889566 DOI: 10.2353/Ajpath.2010.100399 |
0.654 |
|
| 2010 |
Bennett MS, Joseph A, Ng HL, Goldstein H, Yang OO. Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes. Aids (London, England). 24: 2619-28. PMID 20881472 DOI: 10.1097/Qad.0B013E32833F7B22 |
0.6 |
|
| 2010 |
Sango K, Joseph A, Patel M, Osiecki K, Dutta M, Goldstein H. Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice. Aids Research and Human Retroviruses. 26: 735-46. PMID 20624075 DOI: 10.1089/Aid.2009.0136 |
0.808 |
|
| 2010 |
Schaubert KL, Price DA, Salkowitz JR, Sewell AK, Sidney J, Asher TE, Blondelle SE, Adams S, Marincola FM, Joseph A, Sette A, Douek DC, Ayyavoo V, Storkus W, Leung MY, ... ... Goldstein H, et al. Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes. European Journal of Immunology. 40: 1950-62. PMID 20432235 DOI: 10.1002/Eji.200940079 |
0.603 |
|
| 2010 |
Joseph A, Zheng JH, Chen K, Dutta M, Chen C, Stiegler G, Kunert R, Follenzi A, Goldstein H. Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody. Journal of Virology. 84: 6645-53. PMID 20410262 DOI: 10.1128/Jvi.02339-09 |
0.719 |
|
| 2009 |
Kitchen SG, Bennett M, Gali? Z, Kim J, Xu Q, Young A, Lieberman A, Joseph A, Goldstein H, Ng H, Yang O, Zack JA. Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice. Plos One. 4: e8208. PMID 19997617 DOI: 10.1371/Journal.Pone.0008208 |
0.616 |
|
| 2009 |
Toussi SS, Joseph A, Zheng JH, Dutta M, Santambrogio L, Goldstein H. Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication. Aids Research and Human Retroviruses. 25: 1117-21. PMID 19895343 DOI: 10.1089/Aid.2008.0282 |
0.708 |
|
| 2009 |
Joseph A, Sango K, Goldstein H. Novel mouse models for understanding HIV-1 pathogenesis. Methods in Molecular Biology (Clifton, N.J.). 485: 311-27. PMID 19020834 DOI: 10.1007/978-1-59745-170-3_21 |
0.731 |
|
| 2008 |
Wang H, Sun J, Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. Journal of Virology. 82: 7591-600. PMID 18508884 DOI: 10.1128/Jvi.00768-08 |
0.62 |
|
| 2008 |
Sun J, Zheng JH, Zhao M, Lee S, Goldstein H. Increased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious R5 human immunodeficiency virus type 1 provirus and for CD4-specific expression of human cyclin T1 in response to stimulation by lipopolysaccharides. Journal of Virology. 82: 5562-72. PMID 18353948 DOI: 10.1128/Jvi.02618-07 |
0.664 |
|
| 2008 |
Tallóczy Z, Martinez J, Joset D, Ray Y, Gácser A, Toussi S, Mizushima N, Nosanchuk JD, Nosanchuk J, Goldstein H, Loike J, Sulzer D, Santambrogio L. Methamphetamine inhibits antigen processing, presentation, and phagocytosis. Plos Pathogens. 4: e28. PMID 18282092 DOI: 10.1371/Journal.Ppat.0040028 |
0.458 |
|
| 2008 |
Goldstein H. Summary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop. Aids Research and Therapy. 5: 3. PMID 18237418 DOI: 10.1186/1742-6405-5-3 |
0.614 |
|
| 2008 |
Joseph A, Zheng JH, Follenzi A, Dilorenzo T, Sango K, Hyman J, Chen K, Piechocka-Trocha A, Brander C, Hooijberg E, Vignali DA, Walker BD, Goldstein H. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity. Journal of Virology. 82: 3078-89. PMID 18184707 DOI: 10.1128/Jvi.01812-07 |
0.801 |
|
| 2007 |
Schaubert KL, Price DA, Frahm N, Li J, Ng HL, Joseph A, Paul E, Majumder B, Ayyavoo V, Gostick E, Adams S, Marincola FM, Sewell AK, Altfeld M, Brenchley JM, ... ... Goldstein H, et al. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope. Journal of Immunology (Baltimore, Md. : 1950). 178: 7756-66. PMID 17548613 DOI: 10.4049/Jimmunol.178.12.7756 |
0.529 |
|
| 2007 |
Casadevall A, Goldstein H, Dadachova E. Targeting host cells harbouring viruses with radiolabeled antibodies. Expert Opinion On Biological Therapy. 7: 595-7. PMID 17477798 DOI: 10.1517/14712598.7.5.595 |
0.467 |
|
| 2006 |
Dadachova E, Patel MC, Toussi S, Apostolidis C, Morgenstern A, Brechbiel MW, Gorny MK, Zolla-Pazner S, Casadevall A, Goldstein H. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. Plos Medicine. 3: e427. PMID 17090209 DOI: 10.1371/Journal.Pmed.0030427 |
0.562 |
|
| 2006 |
Sun J, Soos T, Kewalramani VN, Osiecki K, Zheng JH, Falkin L, Santambrogio L, Littman DR, Goldstein H. CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate. Journal of Virology. 80: 1850-62. PMID 16439541 DOI: 10.1128/Jvi.80.4.1850-1862.2006 |
0.684 |
|
| 2006 |
Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1098-106. PMID 16436595 DOI: 10.1523/Jneurosci.3863-05.2006 |
0.597 |
|
| 2005 |
Osiecki K, Xie L, Zheng JH, Squires R, Pettoello-Mantovani M, Goldstein H. Identification of granulocyte-macrophage colony-stimulating factor and lipopolysaccharide-induced signal transduction pathways that synergize to stimulate HIV type 1 production by monocytes from HIV type 1 transgenic mice. Aids Research and Human Retroviruses. 21: 125-39. PMID 15725751 DOI: 10.1089/Aid.2005.21.125 |
0.572 |
|
| 2004 |
Si Q, Cosenza M, Kim MO, Zhao ML, Brownlee M, Goldstein H, Lee S. A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. Journal of Neurovirology. 10: 284-92. PMID 15385251 DOI: 10.1080/13550280490499533 |
0.578 |
|
| 2004 |
Patel M, Goldstein H. Animal models of cancer and HIV. Current Opinion in Oncology. 16: 463-7. PMID 15314516 |
0.419 |
|
| 2004 |
Patel M, Cordelier P, Strayer DS, Goldstein H. 370. Potent In Vivo Inhibition of HIV-1 Infection in Thy/Liv-SCID-Hu Mice after In Vivo Treatment with a Combination of SV40-Derived Vectors Targeting CCR5 Expression Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.310 |
0.681 |
|
| 2003 |
Wang EJ, Sun J, Pettoello-Mantovani M, Anderson CM, Osiecki K, Zhao ML, Lopez L, Lee SC, Berman JW, Goldstein H. Microglia from mice transgenic for a provirus encoding a monocyte-tropic HIV type 1 isolate produce infectious virus and display in vitro and in vivo upregulation of lipopolysaccharide-induced chemokine gene expression. Aids Research and Human Retroviruses. 19: 755-65. PMID 14585206 DOI: 10.1089/088922203769232557 |
0.695 |
|
| 2003 |
Xiao X, Phogat S, Shu Y, Phogat A, Chow YH, Wei OL, Goldstein H, Broder CC, Dimitrov DS. Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity. Vaccine. 21: 4275-84. PMID 14505910 DOI: 10.1016/S0264-410X(03)00494-8 |
0.467 |
|
| 2003 |
Strayer DS, Goldstein H, Cordelier P, Ghosh S, Strayer MS, Pettoello-Mantovani M, Chowdhury J. Using new gene delivery systems to advance HIV gene therapy Clinical and Applied Immunology Reviews. 3: 247-259. DOI: 10.1016/S1529-1049(03)00008-4 |
0.637 |
|
| 2002 |
Wang EJ, Pettoello-Mantovani M, Anderson CM, Osiecki K, Moskowitz D, Goldstein H. Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells. The Journal of Infectious Diseases. 186: 1412-21. PMID 12404156 DOI: 10.1086/344737 |
0.676 |
|
| 2002 |
Si Q, Kim MO, Zhao ML, Landau NR, Goldstein H, Lee S. Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells. Virology. 301: 342-53. PMID 12359436 DOI: 10.1006/Viro.2002.1613 |
0.668 |
|
| 2002 |
Si Q, Cosenza M, Zhao ML, Goldstein H, Lee SC. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. Glia. 39: 174-83. PMID 12112368 DOI: 10.1002/Glia.10095 |
0.553 |
|
| 2002 |
Goldstein H, Pettoello-Mantovani M, Anderson CM, Cordelier P, Pomerantz RJ, Strayer DS. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue. The Journal of Infectious Diseases. 185: 1425-30. PMID 11992277 DOI: 10.1086/340210 |
0.65 |
|
| 2002 |
Zaitseva M, Kawamura T, Loomis R, Goldstein H, Blauvelt A, Golding H. Stromal-derived factor 1 expression in the human thymus. Journal of Immunology (Baltimore, Md. : 1950). 168: 2609-17. PMID 11884424 DOI: 10.4049/Jimmunol.168.6.2609 |
0.417 |
|
| 2001 |
Posada R, Pettoello-Mantovani M, Sieweke M, Graf T, Goldstein H. Suppression of HIV type 1 replication by a dominant-negative Ets-1 mutant. Aids Research and Human Retroviruses. 16: 1981-9. PMID 11153081 DOI: 10.1089/088922200750054710 |
0.662 |
|
| 2000 |
Strayer DS, Pomerantz RJ, Yu M, Rosenzweig M, BouHamdan M, Yurasov S, Johnson RP, Goldstein H. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors. Gene Therapy. 7: 886-95. PMID 10845727 DOI: 10.1038/Sj.Gt.3301159 |
0.396 |
|
| 2000 |
Paul JB, Wang EJ, Pettoello-Mantovani M, Raker C, Yurasov S, Goldstein MM, Horner JW, Chan J, Goldstein H. Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: A new in vivo system for studying the postintegration phase of HIV replication Aids Research and Human Retroviruses. 16: 481-492. PMID 10772534 DOI: 10.1089/088922200309142 |
0.794 |
|
| 2000 |
Goldstein H, Pettoello-Mantovani M, Bera TK, Pastan IH, Berger EA. Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice. The Journal of Infectious Diseases. 181: 921-6. PMID 10720513 DOI: 10.1086/315351 |
0.688 |
|
| 2000 |
Yurasov SV, Pettoello-Mantovani M, Raker CA, Goldstein H. HIV type 1 infection of human fetal bone marrow cells induces apoptotic changes in hematopoietic precursor cells and suppresses their in vitro differentiation and capacity to engraft SCID mice. Aids Research and Human Retroviruses. 15: 1639-52. PMID 10606087 DOI: 10.1089/088922299309685 |
0.7 |
|
| 1999 |
Rubinstein A, Mizrachi Y, Pettoello-Mantovani M, Lenz J, Liu GQ, Rubinstein Y, Goldstein H, Yust I, Burke M, Vardinon N, Spirer Z, Cryz SJ. Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates. Journal of Acquired Immune Deficiency Syndromes (1999). 22: 467-76. PMID 10961608 DOI: 10.1097/00126334-199912150-00007 |
0.545 |
|
| 1999 |
Rubinstein A, Mizrachi Y, Pettoello-Mantovani M, Lenz J, Liu G, Rubinstein Y, Goldstein H, Yust I, Burke M, Vardinon N, Spirer Z, Cryz SJ. Immunologic Responses of HIV-1–Infected Study Subjects to Immunization With a Mixture of Peptide Protein Derivative–V3 Loop Peptide Conjugates Journal of Acquired Immune Deficiency Syndromes. 22: 467. DOI: 10.1097/00042560-199912150-00007 |
0.328 |
|
| 1998 |
Kim A, Pettoello-Mantovani M, Goldstein H. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 19: 145-9. PMID 9768623 DOI: 10.1097/00042560-199810010-00007 |
0.662 |
|
| 1998 |
Pettoello-Mantovani M, Kollmann TR, Katopodis NF, Raker C, Kim A, Yurasov S, Wiltshire H, Goldstein H. thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues. The Journal of Infectious Diseases. 177: 337-46. PMID 9466519 DOI: 10.1086/514214 |
0.603 |
|
| 1998 |
Browning J, Horner JW, Pettoello-Mantovani M, Raker C, Yurasov S, DePinho RA, Goldstein H. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proceedings of the National Academy of Sciences of the United States of America. 94: 14637-41. PMID 9405665 DOI: 10.1073/Pnas.94.26.14637 |
0.678 |
|
| 1998 |
Gibbons C, Kollmann TR, Pettoello-Mantovani M, Kim A, Goldstein H. Thy/Liv-SCID-Hu mice implanted with human intestine: an in vivo model for investigation of mucosal transmission of HIV. Aids Research and Human Retroviruses. 13: 1453-60. PMID 9390744 DOI: 10.1089/Aid.1997.13.1453 |
0.667 |
|
| 1997 |
Pettoello-Mantovani M, Kollmann TR, Raker C, Kim A, Yurasov S, Tudor R, Wiltshire H, Goldstein H. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Antimicrobial Agents and Chemotherapy. 41: 1880-7. PMID 9303378 DOI: 10.1128/Aac.41.9.1880 |
0.695 |
|
| 1997 |
Lee S, Goldstein H, Baseler M, Adelsberger J, Golding H. Human immunodeficiency virus type 1 infection of mature CD3hiCD8+ thymocytes. Journal of Virology. 71: 6671-6. PMID 9261389 DOI: 10.1128/Jvi.71.9.6671-6676.1997 |
0.666 |
|
| 1997 |
Yurasov S, Kollmann TR, Kim A, Raker CA, Hachamovitch M, Wong-Staal F, Goldstein H. Severe combined lmmunodeficiency mice engrafted with human T cells, B cells, and myeloid cells after transplantation with human fetal bone marrow or liver cells and implanted with human fetal thymus: A model for studying human gene therapy Blood. 89: 1800-1810. PMID 9057666 DOI: 10.1182/Blood.V89.5.1800.1800_1800_1810 |
0.374 |
|
| 1997 |
Goldstein H, Pettoello-Mantovani M, Katopodis NF, Kim A, Yurasov S, Kollmann TR. SCID-hu mice: a model for studying disseminated HIV infection. Seminars in Immunology. 8: 223-31. PMID 8883145 DOI: 10.1006/Smim.1996.0028 |
0.624 |
|
| 1996 |
Kollmann TR, Pettoello-Mantovani M, Katopodis NF, Hachamovitch M, Rubinstein A, Kim A, Goldstein H. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. Proceedings of the National Academy of Sciences of the United States of America. 93: 3126-31. PMID 8610180 DOI: 10.1073/Pnas.93.7.3126 |
0.656 |
|
| 1995 |
Pettoello-Mantovani M, Casadevall A, Smarnworawong P, Goldstein H. Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae. Aids Research and Human Retroviruses. 10: 1079-87. PMID 7826695 DOI: 10.1089/Aid.1994.10.1079 |
0.629 |
|
| 1995 |
Cryz SJ, Goldstein H, Pettoello-Mantovani M, Kim A, Fürer E, Que JU, Hasler T, Rubinstein A. Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine Vaccine. 13: 67-71. PMID 7762281 DOI: 10.1016/0264-410X(95)80013-4 |
0.517 |
|
| 1995 |
Rubinstein A, Goldstein H, Pettoello-Mantovani M, Mizrachi Y, Bloom BR, Furer E, Althaus B, Que JU, Hasler T, Cryz SJ. Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers Aids. 9: 243-252. DOI: 10.1097/00002030-199503000-00005 |
0.585 |
|
| 1994 |
Kollmann TR, Pettoello-Mantovani M, Zhuang X, Kim A, Hachamovitch M, Smarnworawong P, Rubinstein A, Goldstein H. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. The Journal of Experimental Medicine. 179: 513-22. PMID 8294863 DOI: 10.1084/Jem.179.2.513 |
0.705 |
|
| 1994 |
Pettoello-Mantovani M, Casadevall A, Goldstein H. The presence of cryptococcal capsular polysaccharide increases the sensitivity of HIV-1 coculture in children. Annals of the New York Academy of Sciences. 693: 281-3. PMID 8267279 DOI: 10.1111/J.1749-6632.1993.Tb26283.X |
0.554 |
|
| 1994 |
Kollmann TR, Kim A, Zhuang X, Hachamovitch M, Goldstein H. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. Proceedings of the National Academy of Sciences of the United States of America. 91: 8032-6. PMID 7914701 DOI: 10.1073/Pnas.91.17.8032 |
0.339 |
|
| 1993 |
Kollmann TR, Goldstein MM, Goldstein H. The concurrent maturation of mouse and human thymocytes in human fetal thymus implanted in NIH-beige-nude-xid mice is associated with the reconstitution of the murine immune system. The Journal of Experimental Medicine. 177: 821-32. PMID 8436912 DOI: 10.1084/Jem.177.3.821 |
0.445 |
|
| 1993 |
Rubinstein A, Goldstein H, Calvelli T, Devash Y, Rubinstein R, Soeiro R, Lyman W. Maternofetal transmission of human immunodeficiency virus-1: the role of antibodies to the V3 primary neutralizing domain. Pediatric Research. 33: S76-8; discussion S7. PMID 8433879 DOI: 10.1203/00006450-199305001-00440 |
0.528 |
|
| 1993 |
Suarez MA, Blanco B, Brion LP, Schulman M, Calvelli TA, Youchah J, Devash Y, Rubinstein A, Goldstein H. A rapid test for the detection of human immunodeficiency virus antibodies in cord blood The Journal of Pediatrics. 123: 259-261. PMID 8345422 DOI: 10.1016/S0022-3476(05)81698-1 |
0.353 |
|
| 1993 |
Cryz SJ, Goldstein H, Furer E, Que JU, Hasler T, Althaus B, Rubinstein A. Prospects for prevention of vertical transmission of human immunodeficiency virus by immunization Annals of the New York Academy of Sciences. 693: 194-201. PMID 8267263 DOI: 10.1111/J.1749-6632.1993.Tb26268.X |
0.365 |
|
| 1993 |
Rubinstein A, Goldstein H, Calvelli T, Devash Y, Rubinstein R, Soeiro R, Lyman W. Maternofetal Transmission of Human Immunodeficiency Virus-1: the Role of Antibodies to the V3 Primary Neutralizing Domain Pediatric Research. 33: S76-S79. DOI: 10.1203/00006450-199304001-00014 |
0.323 |
|
| 1992 |
Goldstein H, Pettoello-Mantovani M, Kollmann TR, Calvelli TA, Rubinstein A. Inhibition of HIV-1 infection by alkylureas. Aids (London, England). 5: 1447-52. PMID 1726039 DOI: 10.1097/00002030-199112000-00006 |
0.686 |
|
| 1992 |
Kollmann TR, Zhuang X, Rubinstein A, Goldstein H. Design of polymerase chain reaction primers for the selective amplification of HIV-1 RNA in the presence of HIV-1 DNA. Aids (London, England). 6: 547-52. PMID 1388875 DOI: 10.1097/00002030-199206000-00004 |
0.574 |
|
| 1992 |
Pettoello-Mantovani M, Casadevall A, Kollmann TR, Rubinstein A, Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet (London, England). 339: 21-3. PMID 1370335 DOI: 10.1016/0140-6736(92)90142-P |
0.655 |
|
| 1991 |
Kollmann TR, Rubinstein A, Lyman WD, Soeiro R, Goldstein H. Characterization of IgG and IgG subclass antibodies present in paired maternal and fetal serum which are directed against HIV-1 proteins. Aids Research and Human Retroviruses. 7: 847-54. PMID 1742077 DOI: 10.1089/Aid.1991.7.847 |
0.554 |
|
| 1991 |
Wiseman G, Rubinstein A, Martinez P, Lambert S, Devash Y, Goldstein H. Cellular and antibody responses directed against the HIV-1 principal neutralizing domain in HIV-1-infected children. Aids Research and Human Retroviruses. 7: 839-45. PMID 1742076 DOI: 10.1089/Aid.1991.7.839 |
0.634 |
|
| Show low-probability matches. |